Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Zydus Lifesciences Ltd.

NSE: ZYDUSLIFE | BSE: 532321 | ISIN: INE010B01027 | Industry: Pharmaceuticals
| Mid-range Performer

967.6500 -0.80 (-0.08%)

NSE Jul 15, 2025 15:31 PM

26.93% Fall from 52W High

Volume: 553.3K

Zydus Lifesciences Ltd.

16 Sep 2022

967.65

-0.08%

Company Update

Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

BSE India

Press release dated September 16, 2022 titled 'Zydus receives tentative approval from the USFDA for Sugammadex Injection'

More from Zydus Lifesciences Ltd.

Recommended

Five stocks to buy from analysts this week - July 15, 2025

The Baseline | 15 Jul 2025, 06:44PM

Market closes higher, ICICI Prudential's Q1 net profit surges 34.2% YoY to Rs 301 crore

Trendlyne Marketwatch | 15 Jul 2025, 03:56PM

Earnings Call Transcript - Cadila Healthcare

| 14 Feb 2020, 01:51PM